Merging our Strengths: Vesper Medical acquired by Philips to expand its therapeutic devices portfolio Read More

Shaping the Future of Treating Deep Venous Disease

The Vesper DUO Venous Stent System® is designed to be the next generation venous stent portfolio uniquely engineered to address the multiple anatomical challenges of the deep venous system for the broad range of patients with Chronic Venous Insufficiency (CVI).

The VIVID Clinical Trial is currently recruiting adult patients that have CVI and are eligible for a venous stent in their iliac or common femoral veins.

Our Stent Portfolio VIVID Trial Details

Vesper DUO Venous Stent System: DUO-HYBRID and DUO-EXTEND Stents

Watch the video to learn more about this next generation venous stent portfolio.

Venous News Interview with Dr. Mahmood Razavi, VIVID trial national PI

Dr. Razavi discusses the VIVID trial and how it will provide new insights for venous stenting and how using DUO-HYBRID and DUO-EXTEND may reduce the need to mix and match stents.

Vesper Medical in the news

Vesper Medical Announces Completion of Enrollment in the VIVID Clinical Trial
Read More >

Stacy Enxing Seng Joins the Vesper Medical Board of Directors Read More >

Vesper Medical Announces First Enrollment in the VIVID Trial Read More >

Vesper Medical Logo

Contact us for information about Vesper Medical and the VIVID clinical study

* Required Field

Scroll to Top